GRAL

GRAIL Inc · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website grail.com
Employees(FY) -
ISIN US3847471014

Performance

-14.37%

-25.96%

-7.1%

YTD

-7.1%

Profile

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.

Advanced Technical Analysis

Stock Analysis of GRAL

Stock Rank

Recent News & Updates

2024-09-02 23:37
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal(Yahoo Finance)
2024-08-30 05:55
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)(Prnewswire)
2024-08-29 16:16
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology(PR Newswire)
2024-08-29 04:16
Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology(Prnewswire)
2024-08-22 16:11
Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing(MT Newswires)
2024-08-22 16:10
Grail Insider Sold Shares Worth $254,121, According to a Recent SEC Filing(MT Newswires)
2024-08-21 16:01
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(PR Newswire)
2024-08-21 04:01
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(Prnewswire)
2024-08-17 10:05
Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now?(Insidermonkey)
2024-08-16 08:01
10 Cheap Robotics Stocks To Buy(Insidermonkey)
2024-08-14 08:07
Grail to shed 350 workers in restructuring(MedTech Dive)
2024-08-13 17:16
Grail Q2 Net Loss Widens, Revenue Rises; Cost Cuts Planned; Shares Jump After Hours(MT Newswires)
2024-08-13 16:01
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update(PR Newswire)
2024-08-13 04:01
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update(Prnewswire)
2024-08-08 08:05
Wheels Up Announces Gregory Summe to Join Board of Directors(PR Newswire)
2024-08-07 20:05
Wheels Up Announces Gregory Summe to Join Board of Directors(Prnewswire)
2024-07-31 16:05
GRAIL to Announce Second Quarter 2024 Financial Results(PR Newswire)
2024-07-31 04:05
GRAIL to Announce Second Quarter 2024 Financial Results(Prnewswire)
2024-07-23 20:55
Heres Why You Should Add Illumina (ILMN) to Your Portfolio(Yahoo Finance)
2024-07-19 06:53
Grail announces first patients enrolled in REACH cancer trial(Medical Device Network)
2024-07-18 09:00
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population(PR Newswire)
2024-07-17 21:00
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri Multi-Cancer Early Detection (MCED) Test in the Medicare Population(Prnewswire)
2024-07-17 06:30
3 Top Cancer Treatment Stocks to Buy Now(InvestorPlace)
2024-07-15 12:31
3 Spinoff Stocks You Should Buy Now: July 2024(InvestorPlace)
2024-07-15 09:14
Sector Update: Health Care Stocks Edge Higher Premarket Monday(MT Newswires)
2024-07-15 03:53
Grail Completes Enrollment in US Study for Cancer Early-Detection Device(MT Newswires)
2024-07-15 03:01
GRAIL Advances the Galleri® Registrational Clinical Trial Program(PR Newswire)
2024-07-15 00:31
3 Spinoff Stocks You Should Buy Now: July 2024(Investorplace)
2024-07-14 15:01
GRAIL Advances the Galleri Registrational Clinical Trial Program(Prnewswire)
2024-07-05 06:55
3 Biotech Stocks Turning DNA Dreams Into Dollars(InvestorPlace)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.